EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Extractable organofluorine (EOF) and target PFAS, including trifluoroacetic acid (TFA), in human serum from a Norwegian cohort, with a case study on the impact of fluorinated pharmaceuticals

Leo W Y Yeung, Trine Husøy, Enmiao Jiao, Welmoed Nauta, Dorte Herzke, Line Småstuen Haug, Jana K Geuer, Monica Andreassen, Hubert Dirven

Environment International · 2026-05 · 211 · 110280

DOI: 10.1016/j.envint.2026.110280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environment International, 2026-05. Verfasst von Leo W Y Yeung und 8 weiteren Autor:innen. Beteiligte Einrichtung: Man-Technology-Environment (MTM) Research Centre, School of Science and Technology, Örebro University, 701 82 Örebro, Sweden. Electronic address: Leo…. Hauptthemen laut MEDLINE: Fluorocarbons, Trifluoroacetic Acid, Environmental Pollutants, Environmental Exposure. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020, Formas, Norwegian Institute of Public Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the amount and proportion of unidentified organofluorine (UOF) in human serum and assessed short-term variability in exposure using extractable organofluorine (EOF) analysis and a fluorine mass balance approach. Serum samples were obtained from the well-characterized EuroMix cohort, comprising residents living in and around Oslo, Norway, collected between September 2016 and November 2017. Short-term intra-individual variability was evaluated using 72 paired serum samples collected 2-3 weeks apart. An extended target list of 64 PFAS, including trifluoroacetic acid (TFA), was applied to quantify identified and unidentified EOF. UOF accounted for up to 81% of EOF (median: 38%) in EuroMix samples. In 36% of paired samples, EOF concentrations varied by more than 25% over the 2-3-week interval, indicating the presence of compounds with relatively short biological half-lives. TFA was the most abundant individual PFAS detected, with median concentrations approximately twice those of PFOS. In a separate case study, serum samples from individuals using the fluorinated pharmaceutical Fluoxetine showed substantially elevated EOF and TFA concentrations (EOF: median 140 ng F/mL; TFA: median 27.7 ng/mL) compared with samples from individuals not using Fluoxetine (EOF: median < 8 ng F/mL; TFA: median 6.22 ng/mL). These findings indicate that fluorinated pharmaceuticals may contribute significantly to circulating EOF and TFA in humans. The large fraction of UOF and the widespread occurrence of TFA highlight the need to identify their sources relevant to human exposure. Together, these findings indicate that current PFAS including TFA biomonitoring approaches capture only a fraction (estimated to be 50%) of total human exposure to fluorinated substances and highlight the need to complement target analysis with fluorine mass balance approaches in future exposure assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FluorocarbonsTrifluoroacetic AcidEnvironmental PollutantsEnvironmental ExposureHumansNorwayCohort StudiesFemaleEnvironmental Monitoring

Stichwörter der Autor:innen

Extractable organofluorineFluorinated pharmaceuticalsFluoxetineMass balance analysisPFASProzacSerumTrifluoroacetic acid

Substanzen

FluorocarbonsTrifluoroacetic AcidEnvironmental Pollutants

Autor:innen und Institutionen

  • Man-Technology-Environment (MTM) Research Centre, School of Science and Technology, Örebro University, 701 82 Örebro, Sweden. Electronic address: Leo.Yeung@oru.se.
  • Department of Food Safety, Division of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
  • Man-Technology-Environment (MTM) Research Centre, School of Science and Technology, Örebro University, 701 82 Örebro, Sweden.
  • Department of Chemical Toxicology, Division of Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.

Förderung

  • Horizon 2020
  • Formas
  • Norwegian Institute of Public Health
  • Nordic Council of Ministers
  • Horizon 2020 Framework Programme
  • Svenska Forskningsrådet Formas

Zitieren

APA

Yeung, L. W. Y., Husøy, T., Jiao, E., Nauta, W., Herzke, D., Haug, L. S., Geuer, J. K., Andreassen, M., & Dirven, H. (2026). Extractable organofluorine (EOF) and target PFAS, including trifluoroacetic acid (TFA), in human serum from a Norwegian cohort, with a case study on the impact of fluorinated pharmaceuticals. Environment International, 211, 110280. https://doi.org/10.1016/j.envint.2026.110280

Vancouver

Yeung LWY, Husøy T, Jiao E, Nauta W, Herzke D, Haug LS, et al. Extractable organofluorine (EOF) and target PFAS, including trifluoroacetic acid (TFA), in human serum from a Norwegian cohort, with a case study on the impact of fluorinated pharmaceuticals. Environment International. 2026;211:110280. doi:10.1016/j.envint.2026.110280

BibTeX
@article{Yeung2026,
  author = {Yeung, Leo W Y and Husøy, Trine and Jiao, Enmiao and Nauta, Welmoed and Herzke, Dorte and Haug, Line Småstuen and Geuer, Jana K and Andreassen, Monica and Dirven, Hubert},
  title = {Extractable organofluorine (EOF) and target PFAS, including trifluoroacetic acid (TFA), in human serum from a Norwegian cohort, with a case study on the impact of fluorinated pharmaceuticals},
  journal = {Environment International},
  year = {2026},
  volume = {211},
  pages = {110280},
  doi = {10.1016/j.envint.2026.110280}
}
Kostenlos starten →